PROCEPT BioRobotics Corporation (PRCT) Stock

Healthcare · Medical Devices · Member of Other US Stocks

PROCEPT BioRobotics Corporation (PRCT) closed at USD 17.51 on 2026-10-14, a change of -52.6 % over the past year, with a market capitalization of USD 1.04B.

PROCEPT BioRobotics Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

PROCEPT BioRobotics Corporation key figures

Previous close

USD 17.51 (2026-10-14)

1-year change

-52.6 %

Market cap

USD 1.04B

Enterprise value

USD 889.1M

P/E ratio (trailing)

-9.86

P/E ratio (forward)

-15.49

EPS (trailing)

-1.84

EPS (forward)

-1.17

PEG ratio

n/a

Price to book

3.06

Revenue growth

19.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.41

Employees

888

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for PROCEPT BioRobotics Corporation and compare it with other stocks.